Thomas Hallam
Director of Finance/CFO en GIVAUDAN SA .
Fortuna: 3 M $ al 31/03/2024
Perfil
En la actualidad, Tom Hallam es Director Financiero de Givaudan SA. El Sr. Hallam es también miembro del Chartered Institute of Management Accountants. En su anterior carrera, el Sr. Hallam fue Vicepresidente de Finanzas Corporativas en Serono SA. El Sr. Hallam se licenció en la Universidad de Manchester.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
GIVAUDAN SA
0.01% | 31/12/2023 | 594 ( 0.01% ) | 3 M $ | 31/03/2024 |
Cargos activos de Thomas Hallam
Empresas | Cargo | Inicio |
---|---|---|
GIVAUDAN SA | Director of Finance/CFO | 01/01/2017 |
AZELIS GROUP NV | Director/Board Member | 02/08/2022 |
The Chartered Institute of Management Accountants
The Chartered Institute of Management Accountants Other Consumer ServicesConsumer Services The Chartered Institute of Management Accountants, also known as aicpa® & cima®, is a global organization with 689,000 members, students, and professionals. The non-profit company is based in London, UK, and has a global presence of subsidiaries in several regions. The British company advocates for the accounting and finance profession, as well as the public interest and business sustainability. Andrew Harding has been the CEO of the company since 2009. | Corporate Officer/Principal | - |
Azelis SA
Azelis SA Wholesale DistributorsDistribution Services Azelis SA engages in distribution of specialty chemicals. Its services include sampling, logistics, application laboratories, reach regulation, and food development kitchens. It caters to the animal nutrition, food and health, home care and industrial cleaning, personal care, pharmaceutical, electronics, lubricants and metalworking fluids, oilfield, rubber and plastic additives, textiles, and leather and paper industries. The company was founded by Hans Udo Wenzel in 1996 and is headquartered in Munsbach, Luxembourg. | Director/Board Member | - |
Antiguos cargos conocidos de Thomas Hallam.
Empresas | Cargo | Fin |
---|---|---|
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | Corporate Officer/Principal | - |
Formación de Thomas Hallam.
The University of Manchester | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
GIVAUDAN SA | Consumer Non-Durables |
AZELIS GROUP NV | Distribution Services |
Empresas privadas | 3 |
---|---|
The Chartered Institute of Management Accountants
The Chartered Institute of Management Accountants Other Consumer ServicesConsumer Services The Chartered Institute of Management Accountants, also known as aicpa® & cima®, is a global organization with 689,000 members, students, and professionals. The non-profit company is based in London, UK, and has a global presence of subsidiaries in several regions. The British company advocates for the accounting and finance profession, as well as the public interest and business sustainability. Andrew Harding has been the CEO of the company since 2009. | Consumer Services |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | Health Technology |
Azelis SA
Azelis SA Wholesale DistributorsDistribution Services Azelis SA engages in distribution of specialty chemicals. Its services include sampling, logistics, application laboratories, reach regulation, and food development kitchens. It caters to the animal nutrition, food and health, home care and industrial cleaning, personal care, pharmaceutical, electronics, lubricants and metalworking fluids, oilfield, rubber and plastic additives, textiles, and leather and paper industries. The company was founded by Hans Udo Wenzel in 1996 and is headquartered in Munsbach, Luxembourg. | Distribution Services |
- Bolsa de valores
- Insiders
- Thomas Hallam